Current
$4.44B
5-Year Average
$806.57M
All-Time High
$4.53B
All-Time Low
$119.55M
Market cap daily chart for Tango Therapeutics (TNGX)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
Market Cap growth chart for Tango Therapeutics (TNGX) from 2020 to 2026
Latest: +331.6%
Market Cap history table for Tango Therapeutics (TNGX) from 2020 to 2026
| 2026 | $4.44B | +331.6% | +$3.41B | ||
| 2025 | $1.03B | +204.9% | +$691.72M | ||
| 2024 | $337.51M | -64.0% | −$598.76M | ||
| 2023 | $936.27M | +47.1% | +$299.57M | ||
| 2022 | $636.70M | -6.3% | −$42.77M | ||
| 2021 | $679.46M | -32.1% | −$321.24M | ||
| 2020 | $1.00B | — | — |
- 2026$4.44B+331.6%
- 2025$1.03B+204.9%
- 2024$337.51M-64.0%
- 2023$936.27M+47.1%
- 2022$636.70M-6.3%
- 2021$679.46M-32.1%
- 2020$1.00B—
Market Cap values are taken from Tango Therapeutics's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported market cap is $3.00B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Tango Therapeutics (TNGX) market cap totalled $4.44B – surged 331.6% year-over-year.
Through 2021–2026 (5 years), Tango Therapeutics market cap delivered a +45.6% annualised rate; sustaining 2 straight years of year-over-year growth.
The record annual market cap stands at $4.44B, reached in 2026; the historical low of $337.51M was recorded in 2024.
Tango Therapeutics Market Cap by Year
Tango Therapeutics Market Cap 2026: $4.44B
2026's market cap for Tango Therapeutics came in at $4.44B, surged 331.6% from 2025. This figure represents the highest annual value in the available history.
Tango Therapeutics Market Cap 2025: $1.03B
Tango Therapeutics posted market cap of $1.03B in 2025, surged 204.9% from 2024.
Tango Therapeutics Market Cap 2024: $337.51M
In 2024, Tango Therapeutics reported market cap of $337.51M, plunged 64.0% below 2023. This figure represents the lowest annual value in the available history.
Tango Therapeutics Market Cap 2023: $936.27M
Tango Therapeutics market cap in 2023 was $936.27M, surged 47.1% from 2022.
Tango Therapeutics Market Cap 2022: $636.70M
Tango Therapeutics market cap in 2022 was $636.70M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Market Cap
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $402.35B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $402.35B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation